Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Japan”

A Study to Test Whether BI 1819479 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)Completed
NCT06335303Phase 2Updated Jul 27, 2026
Sponsor: Boehringer Ingelheim
Idiopathic Pulmonary Fibrosis
United States, Argentina, Australia, Austria, Belgium +23 more
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast CancerRecruiting
NCT05894239Phase 3Updated Jul 27, 2026
Sponsor: Hoffmann-La Roche
Metastatic Breast Cancer
United States, Argentina, Australia, Belgium, Brazil +24 more
A Study to Evaluate the Efficacy and Safety of KarXT in Acutely Psychotic Japanese Adult Participants With SchizophreniaRecruiting
NCT06882785Phase 3Updated Jul 27, 2026
Sponsor: Bristol-Myers Squibb
Schizophrenia
Japan
A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab in Prurigo NodularisTerminated
NCT06527404Phase 3Updated Jul 27, 2026
Sponsor: Amgen
Prurigo Nodularis
United States, Argentina, Australia, Austria, Belgium +25 more
Phase 1b Study of Dato-DXd in Combination With Immunotherapy With or Without Carboplatin in Advanced or Metastatic Non-Small Cell Lung CancerActive Not Recruiting
NCT04612751Phase 1Updated Jul 27, 2026
Sponsor: AstraZeneca
Advanced or Metastatic NSCLC
United States, Belgium, Italy, Japan, Poland +3 more
Fasenra Pediatric Japan Post-Marketing Study(PMS)Active Not Recruiting
NCT06427876N/AUpdated Jul 27, 2026
Sponsor: AstraZeneca
Bronchial Asthma
Japan
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I DisorderRecruiting
NCT06951698Phase 3Updated Jul 27, 2026
Sponsor: Bristol-Myers Squibb
Bipolar-I Disorder With Mania or Mania With Mixed Features
United States, Argentina, Australia, Bulgaria, Hungary +4 more
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia GravisRecruiting
NCT04951622Phase 3Updated Jul 27, 2026
Sponsor: Janssen Research & Development, LLC
Myasthenia Gravis
United States, Australia, Belgium, Canada, China +12 more
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation (DIAN-TU)Active Not Recruiting
NCT05269394Phase 2, Phase 3Updated Jul 27, 2026
Sponsor: Washington University School of Medicine
Alzheimers Disease · Dementia · Alzheimers Disease, Familial
United States, Argentina, Australia, Brazil, Canada +11 more
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid ArthritisCompleted
NCT03025308Phase 3Updated Jul 27, 2026
Sponsor: Alfasigma S.p.A.
Rheumatoid Arthritis
United States, Argentina, Australia, Belgium, Bulgaria +27 more
Clinical Practice of Hydromorphone in Multimodal Analgesia for Enhanced Recovery After Surgery (ERAS) in Knee ArthroplastyCompleted
NCT07722234NAUpdated Jul 27, 2026
Sponsor: China-Japan Friendship Hospital
VAS Score · Quadriceps Strength
China
A Study to Test the Safety and Tolerability of Brivaracetam in Children and Adolescents With SeizuresRecruiting
NCT04715646Phase 3Updated Jul 27, 2026
Sponsor: UCB Biopharma SRL
Epilepsy
United States, Belgium, Czechia, France, Germany +6 more
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary DiseaseRecruiting
NCT07363694Phase 2, Phase 3Updated Jul 27, 2026
Sponsor: Pfizer
Moderate to Severe Chronic Obstructive Pulmonary Disease
United States, Argentina, Canada, China, India +3 more
Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus ErythematosusActive Not Recruiting
NCT04877691Phase 3Updated Jul 27, 2026
Sponsor: AstraZeneca
Systemic Lupus Erythematosus
United States, Argentina, Bulgaria, Chile, Colombia +10 more
Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular CarcinomaActive Not Recruiting
NCT03298451Phase 3Updated Jul 27, 2026
Sponsor: AstraZeneca
Hepatocellular Carcinoma
United States, Brazil, Canada, China, France +12 more
Verification Study of the Effects of Consumption of the Test Food on the Musculoskeletal SystemNot Yet Recruiting
NCT07729657NAUpdated Jul 27, 2026
Sponsor: Bloomage Biotechnology Corp., Ltd.
Healthy Japanese Individuals
Japan
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001Active Not Recruiting
NCT01760005Phase 2, Phase 3Updated Jul 27, 2026
Sponsor: Washington University School of Medicine
Alzheimers Disease · Dementia · Alzheimers Disease, Familial
United States, Argentina, Australia, Brazil, Canada +10 more
A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)Recruiting
NCT06818643Phase 1, Phase 2Updated Jul 27, 2026
Sponsor: Merck Sharp & Dohme LLC
Advanced Solid Tumors · Malignant Neoplasm
United States, Chile, China, France, Israel +7 more
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic CancerRecruiting
NCT07409272Phase 3Updated Jul 27, 2026
Sponsor: Astellas Pharma Global Development, Inc.
Pancreatic Cancer · Metastatic Pancreatic Cancer · Metastatic Pancreatic Adenocarcinoma
United States, Japan
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASHRecruiting
NCT07221227Phase 3Updated Jul 27, 2026
Sponsor: GlaxoSmithKline
Non-alcoholic Fatty Liver Disease
United States, Australia, Canada, Hong Kong, Japan +4 more
First-Time-in-Human Study of GSK5471713 in Adults With mCRPCRecruiting
NCT07332455Phase 1, Phase 2Updated Jul 24, 2026
Sponsor: GlaxoSmithKline
Neoplasms, Prostate
United States, Australia, Canada, Japan, South Korea
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)Recruiting
NCT06136624Phase 3Updated Jul 24, 2026
Sponsor: Merck Sharp & Dohme LLC
Prostate Cancer Metastatic
United States, Argentina, Australia, Austria, Brazil +31 more
Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of ExacerbationsCompleted
NCT06040086Phase 3Updated Jul 24, 2026
Sponsor: AstraZeneca
Chronic Obstructive Pulmonary Disease (COPD)
United States, Argentina, Belgium, Brazil, Bulgaria +24 more
A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM)Recruiting
NCT07227311Phase 2Updated Jul 24, 2026
Sponsor: GlaxoSmithKline
Multiple Myeloma
United States, France, Germany, Greece, Japan +3 more
Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053)Active Not Recruiting
NCT04634877Phase 3Updated Jul 24, 2026
Sponsor: Merck Sharp & Dohme LLC
Endometrial Neoplasms
United States, Argentina, Austria, Belgium, Canada +23 more

Previous page Next page